Clinical trial
Characterizing the Intraocular Scattering at Different Wavelengths
NCT05602623 is registered in ClinicalTrials.gov with Johnson & Johnson Vision Care, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterizing the Intraocular Scattering at Different Wavelengths
- Lead sponsor
- Johnson & Johnson Vision Care, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 25, 2023
- Completion date
- June 12, 2024
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vision, ocular